December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

HealthEquity, Inc. - Common Stock (NQ:HQY)

91.07 -0.54 (-0.59%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about HealthEquity, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Expert Outlook: HealthEquity Through The Eyes Of 8 Analysts ↗
 
Via Benzinga
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY
From Pomerantz LLP
Via GlobeNewswire
News headline image
HealthEquity, Inc. Announcement: If You Have Suffered Losses in HealthEquity, Inc. (NASDAQ: HQY) You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY
From Pomerantz LLP
Via GlobeNewswire
News headline image
Rosen Law Firm Encourages HealthEquity, Inc. Investors to Inquire About Securities Class Action Investigation – HQY
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY
From Pomerantz LLP
Via GlobeNewswire
News headline image
HealthEquity Earns Stock Upgrade Despite Fraud Concerns ↗
HealthEquity's Q4 revenue beat estimates, but EPS missed. Raymond James upgraded the stock to Strong Buy, citing long-term growth despite fraud concerns. 
Via Benzinga
Topics Fraud
News headline image
Avalo Therapeutics 'Represents An Attractive Pure-Play,' Analyst Initiates Coverage With Over 300% Stock Upside ↗
Avalo Therapeutics' AVTX-009 is advancing in hidradenitis suppurativa, with Phase 2 data expected in 2026. Stifel initiates coverage with a $36 price target. 
Via Benzinga
News headline image
This Cloudflare Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday ↗
 
Via Benzinga
News headline image
$1000 Invested In HealthEquity 10 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Why HealthEquity Stock Was Sliding This Week ↗
Via The Motley Fool
News headline image
HealthEquity Stock Sees Biggest Drop In Over 3 Years On Disappointing Outlook — Retail Doesn't Feel It's All Doom And Gloom ↗
CFO James Lucania said on the earnings call that fraud prevention efforts are ongoing, and service expenses are expected to remain elevated through the first half of fiscal 2026. 
Via Stocktwits
Topics Earnings Fraud
News headline image
4 Analysts Assess HealthEquity: What You Need To Know ↗
 
Via Benzinga
News headline image
HealthEquity's Long-Term Growth Intact Despite Short-Term Margin Pressures, Analyst Says ↗
HealthEquity reported 19% revenue growth but missed Q4 EPS estimates. Analysts see earnings improving as cybersecurity costs ease and HSA growth continues. 
Via Benzinga
News headline image
Dow, Nasdaq Rally Ahead Of Interest Rate Decision ↗
Stocks are rallying ahead of the Federal Reserve's interest rate decision, due out later this afternoon. 
Via Talk Markets
Topics Economy Stocks Stocks / Equities
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Wednesday's session: gap up and gap down stocks ↗
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
Dow Surges Over 200 Points; US Crude Oil Inventories Increase More than Expected ↗
 
Via Benzinga
Topics Stocks
News headline image
Discover the top movers in Wednesday's pre-market session. ↗
Wondering what's happening in Wednesday's pre-market session? Find an overview in this article. 
Via Chartmill
News headline image
Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
US Stocks Likely To Open Higher Ahead Of FOMC Decision: 'Tariffs Remain The Dominant Market Force' Amid Rising Economic Uncertainty, Says Expert ↗
U.S. stock futures advanced on Wednesday ahead of the Federal Open Market Committee's decision on the interest rates. 
Via Benzinga
News headline image
Why StoneCo Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Williams-Sonoma, HealthEquity And 3 Stocks To Watch Heading Into Wednesday ↗
 
Via Benzinga
News headline image
Which stocks are moving after the closing bell on Tuesday? ↗
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
News headline image
HealthEquity Stock Falls After Reporting Q4 Results: Revenue Beat, EPS Miss, Soft Guidance ↗
HealthEquity reports fourth-quarter financial results after the market close on Tuesday and shares are sinking. Here's a rundown of the report. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
US Futures Show Caution Among Investors Ahead Of FOMC Meeting: Analysts Say Only Certainty Is That 'Things Will Remain Uncertain For The Time Being' ↗
U.S. stock futures were flat on Tuesday after a bounce back on Monday. Futures of all four benchmark indices were mixed in premarket trading. 
Via Benzinga
News headline image
Earnings Scheduled For March 18, 2025 ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.